BIOTECH ACQUISITION COMPANY Proceeds from Other Equity
BIOTECH ACQUISITION COMPANY reported Proceeds from Other Equity of $226.00 million for the 12-month period ending 2021-12-31, per its 10-K filed 2022-03-08.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromOtherEquity · last filed 2022-11-22
- BIOTECH ACQUISITION COMPANY proceeds from other equity for the quarter ending 2021-12-31 was $0.00.
- BIOTECH ACQUISITION COMPANY proceeds from other equity for the quarter ending 2021-09-30 was $0.00.
- BIOTECH ACQUISITION COMPANY proceeds from other equity for the quarter ending 2021-06-30 was $0.00.
- BIOTECH ACQUISITION COMPANY proceeds from other equity for the quarter ending 2021-03-31 was $226.00M.
- BIOTECH ACQUISITION COMPANY proceeds from other equity for fiscal 2021 was $226.00M.
| Period end | Proceeds from Other Equity 1 month | Proceeds from Other Equity 3 month | Proceeds from Other Equity 4 month | Proceeds from Other Equity 6 month | Proceeds from Other Equity 9 month | Proceeds from Other Equity 12 month |
|---|---|---|---|---|---|---|
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-08 | $0.00 derived: sum of 2 quarters · filed 2022-11-22 | $0.00 derived: sum of 3 quarters · filed 2022-11-22 | $226.00M 10-K · filed 2022-03-08 | ||
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-22 | $0.00 derived: sum of 2 quarters · filed 2022-11-22 | $226.00M 10-Q · filed 2022-11-22 | |||
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-22 | $226.00M 10-Q · filed 2022-08-22 | ||||
| 2021-03-31 | $226.00M 10-Q · filed 2022-05-16 | |||||
| 2020-12-31 | $5.00K 10-K · filed 2021-03-23 | |||||
| 2020-09-30 | $5.00K 10-Q · filed 2021-03-11 |